- Home
- IGC vs SHOT Comparison
IGC vs SHOT Comparison
Compare IGC & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- SHOT
- Stock Information
- Founded
- IGC 2005
- SHOT 2018
- Country
- IGC United States
- SHOT United States
- Employees
- IGC N/A
- SHOT N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- SHOT Biotechnology: Pharmaceutical Preparations
- Sector
- IGC Health Care
- SHOT Health Care
- Exchange
- IGC Nasdaq
- SHOT Nasdaq
- Market Cap
- IGC 29.4M
- SHOT 38.9M
- IPO Year
- IGC N/A
- SHOT 2020
- Fundamental
- Price
- IGC $0.31
- SHOT $0.49
- Analyst Decision
- IGC Strong Buy
- SHOT
- Analyst Count
- IGC 2
- SHOT 0
- Target Price
- IGC $3.88
- SHOT N/A
- AVG Volume (30 Days)
- IGC 392.1K
- SHOT 707.0K
- Earning Date
- IGC 02-18-2025
- SHOT 03-31-2025
- Dividend Yield
- IGC N/A
- SHOT N/A
- EPS Growth
- IGC N/A
- SHOT N/A
- EPS
- IGC N/A
- SHOT N/A
- Revenue
- IGC $1,236,000.00
- SHOT $652,495.00
- Revenue This Year
- IGC N/A
- SHOT N/A
- Revenue Next Year
- IGC $18.34
- SHOT N/A
- P/E Ratio
- IGC N/A
- SHOT N/A
- Revenue Growth
- IGC 1.64
- SHOT 68.01
- 52 Week Low
- IGC $0.26
- SHOT $0.41
- 52 Week High
- IGC $0.91
- SHOT $2.89
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- SHOT 47.41
- Support Level
- IGC $0.26
- SHOT $0.43
- Resistance Level
- IGC $0.34
- SHOT $0.60
- Average True Range (ATR)
- IGC 0.02
- SHOT 0.05
- MACD
- IGC 0.01
- SHOT 0.01
- Stochastic Oscillator
- IGC 65.88
- SHOT 42.95
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.